ClinicalTrials.gg
Drug

Satralizumab clinical trials

Also written SA237 and RG6168.

studies test it
14
open now
2
in phase 3
9
first study started
2014

How each study uses satralizumab is sorted by a rule, right about nine times in ten. Readers can ask us to read every study one by one.Ask us to read each study

Get an email when these change. Save the satralizumab studies recruiting or about to start — once a week, free: studies that open, close, add sites or post results.

Get alerts for these studies
See an example email

Example · made-up studies

Breast cancer · Recruiting: 2 came in, 3 changed

What changed in your alerts, Oct 31 – Nov 6:

A study of drug A after surgery for early breast cancer

Came in · now Recruiting

Drug B with hormone therapy in advanced breast cancer

Changed

· Sites: 4 added, including Seoul and Busan

· Enrollment: 300 → 450 participants

Exercise during chemotherapy

Now Active, not recruiting

One email a week for all your alerts. Stop any time.

Approvals

The first approval found in each region, with its record

United States
14 Aug 2020 · ENSPRYNG · BLA 761149 (FDA, Drugs@FDA)
European Union
24 Jun 2021 · Enspryng · EMEA/H/C/004788 (EMA)

From FDA's Drugs@FDA and Purple Book (through openFDA) and the European Medicines Agency, files of Sept 2026 and 27 Oct 2026. National approvals in Europe and other countries are not included. How this is worked out

How studies write it

Studies that test it under each name

Name

Satralizumab
12
Enspryng; RO5333787
2

Brand

Enspryng
1

Development codes

SA237
2
RG6168
2
RO5333787
1

Studies by the year they started

14 studies that test it; most in 2022 (4)

Studies that test satralizumab, by start year
YearStudies
20142
20212
20224
20232
20241
20251
20262

By phase

A phase 1/2 study counts in both.

Early Phase 1
1
Phase 2
2
Phase 3
9
Phase 4
2

What it is tested for

Each study’s main condition, where its own words name it, so a study counts once.

Who runs them

Industry 11 · Other 3

Hoffmann-La Roche (11) · International University of Health and Welfare (1) · Massachusetts General Hospital (1) · University of Florida (1)

Often tested with

Tested in the same studies.

Eculizumab (1) · Ravulizumab (1) · Inebilizumab (1)

Coming up

From the study records. Dates are the sponsors’ own estimates and often move.

Reaching primary completion within a year · 3, 2 in phase 3

Studies that test satralizumab, phase 3 first.

Studies

Open first, then newest update. How each study uses satralizumab is read from its arms, and is right about nine times in ten. Ask us to read each study. These are the studies that list it as an intervention; a search of ClinicalTrials.gov also finds studies that mention it only in a description, such as earlier treatment.

Testing it · 14

Codes

What other systems call satralizumab · ClinicalTrials.gg INT001230

  • MeSH (NLM) C000655944satralizumabConfirmed ClinicalTrials.gov, NLM
  • UNII (FDA) YB18NF020MSATRALIZUMABConfirmed FDA, NLM, Wikidata
  • RxNorm 2391541One source FDA
  • Wikidata Q58218746satralizumabConfirmed FDA, NLM, Wikidata
  • NCI Thesaurus C152307SatralizumabOne source FDA
  • DrugBank DB15762One source Wikidata

“Confirmed” means two independent publishers link the code to this drug; “one source”, one does and its name agrees.